OUR BUSINESS

We strive to deliver cancer cures. As a locally delivered therapy, AIM is expected to have a favorable tolerability profile that will not burden patients, but will expand patient eligibility and improve outcomes especially for patients with limited treatment options.

Get in touch to learn more.